MedTrace Logo

VItamin D as a Novel Determinant of Injurious Cardiac Remodelling After acuTE Myocardial Infarction

NCT03086746 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2018-05-03

No results posted yet for this study

Summary

To provide insight into why vitamin D levels at baseline predict an adverse outcome including hospitalisation, we will establish whether baseline vitamin D levels are an independent marker of LV remodelling in patients experiencing an ST segment elevation myocardial infarction.

Conditions

Sponsors & Collaborators

  • University of Leeds

    lead OTHER

Principal Investigators

  • Klaus K Witte, MD · University of Leeds

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2020-04-01
Completion
2020-06-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03086746 on ClinicalTrials.gov